These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

218 related articles for article (PubMed ID: 36100925)

  • 1. Risk prediction models for incident type 2 diabetes in Chinese people with intermediate hyperglycemia: a systematic literature review and external validation study.
    Xu S; Coleman RL; Wan Q; Gu Y; Meng G; Song K; Shi Z; Xie Q; Tuomilehto J; Holman RR; Niu K; Tong N
    Cardiovasc Diabetol; 2022 Sep; 21(1):182. PubMed ID: 36100925
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Predicting the risk of developing type 2 diabetes in Chinese people who have coronary heart disease and impaired glucose tolerance.
    Xu S; Scott CAB; Coleman RL; Tuomilehto J; Holman RR
    J Diabetes; 2021 Oct; 13(10):817-826. PubMed ID: 33665904
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prediction models for risk of developing type 2 diabetes: systematic literature search and independent external validation study.
    Abbasi A; Peelen LM; Corpeleijn E; van der Schouw YT; Stolk RP; Spijkerman AM; van der A DL; Moons KG; Navis G; Bakker SJ; Beulens JW
    BMJ; 2012 Sep; 345():e5900. PubMed ID: 22990994
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prediction of Five-Year Cardiovascular Disease Risk in People with Type 2 Diabetes Mellitus: Derivation in Nanjing, China and External Validation in Scotland, UK.
    Wan C; Read S; Wu H; Lu S; Zhang X; Wild SH; Liu Y
    Glob Heart; 2022; 17(1):46. PubMed ID: 36051323
    [TBL] [Abstract][Full Text] [Related]  

  • 5. External validation of the KORA S4/F4 prediction models for the risk of developing type 2 diabetes in older adults: the PREVEND study.
    Abbasi A; Corpeleijn E; Peelen LM; Gansevoort RT; de Jong PE; Gans RO; Rathmann W; Kowall B; Meisinger C; Hillege HL; Stolk RP; Navis G; Beulens JW; Bakker SJ
    Eur J Epidemiol; 2012 Jan; 27(1):47-52. PubMed ID: 22215562
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Performance of prediction models for nephropathy in people with type 2 diabetes: systematic review and external validation study.
    Slieker RC; van der Heijden AAWA; Siddiqui MK; Langendoen-Gort M; Nijpels G; Herings R; Feenstra TL; Moons KGM; Bell S; Elders PJ; 't Hart LM; Beulens JWJ
    BMJ; 2021 Sep; 374():n2134. PubMed ID: 34583929
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Development and validation of the CHIME simulation model to assess lifetime health outcomes of prediabetes and type 2 diabetes in Chinese populations: A modeling study.
    Quan J; Ng CS; Kwok HHY; Zhang A; Yuen YH; Choi CH; Siu SC; Tang SY; Wat NM; Woo J; Eggleston K; Leung GM
    PLoS Med; 2021 Jun; 18(6):e1003692. PubMed ID: 34166382
    [TBL] [Abstract][Full Text] [Related]  

  • 8. External Validation of a Tool Predicting 7-Year Risk of Developing Cardiovascular Disease, Type 2 Diabetes or Chronic Kidney Disease.
    Rauh SP; Rutters F; van der Heijden AAWA; Luimes T; Alssema M; Heymans MW; Magliano DJ; Shaw JE; Beulens JW; Dekker JM
    J Gen Intern Med; 2018 Feb; 33(2):182-188. PubMed ID: 29204973
    [TBL] [Abstract][Full Text] [Related]  

  • 9. External validation of prognostic models for chronic kidney disease among type 2 diabetes.
    Saputro SA; Pattanateepapon A; Pattanaprateep O; Aekplakorn W; McKay GJ; Attia J; Thakkinstian A
    J Nephrol; 2022 Jul; 35(6):1637-1653. PubMed ID: 34997924
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prediction of type 2 diabetes risk in people with non-diabetic hyperglycaemia: model derivation and validation using UK primary care data.
    Coles B; Khunti K; Booth S; Zaccardi F; Davies MJ; Gray LJ
    BMJ Open; 2020 Oct; 10(10):e037937. PubMed ID: 33099496
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Plasma metabolomics identified novel metabolites associated with risk of type 2 diabetes in two prospective cohorts of Chinese adults.
    Qiu G; Zheng Y; Wang H; Sun J; Ma H; Xiao Y; Li Y; Yuan Y; Yang H; Li X; Min X; Zhang C; Xu C; Jiang Y; Zhang X; He M; Yang M; Hu Z; Tang H; Shen H; Hu FB; Pan A; Wu T
    Int J Epidemiol; 2016 Oct; 45(5):1507-1516. PubMed ID: 27694567
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Development and External Validation of a Multivariable Prediction Model to Identify Nondiabetic Hyperglycemia and Undiagnosed Type 2 Diabetes: Diabetes Risk Assessment in Dentistry Score (DDS).
    Yonel Z; Kocher T; Chapple ILC; Dietrich T; Völzke H; Nauck M; Collins G; Gray LJ; Holtfreter B
    J Dent Res; 2023 Feb; 102(2):170-177. PubMed ID: 36254392
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Applications of the NDR and DIAL models for risk prediction on cardiovascular disease in patients with type 2 diabetes in Ningbo].
    Li QQ; Liang JY; Wang JM; Shen P; Sun YX; Chen Q; Wu JG; Lu P; Zhang JY; Lin HB; Tang X; Gao P
    Zhonghua Liu Xing Bing Xue Za Zhi; 2022 Jun; 43(6):945-952. PubMed ID: 35725354
    [No Abstract]   [Full Text] [Related]  

  • 14. Performance of Risk Assessment Models for Prevalent or Undiagnosed Type 2 Diabetes Mellitus in a Multi-Ethnic Population-The Helius Study.
    Obura MO; van Valkengoed IG; Rutters F; 't Hart LM; Rauh SP; Moll van Charante EP; Snijder MB; Beulens JWJ
    Glob Heart; 2021 Feb; 16(1):13. PubMed ID: 33598393
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Machine Learning for Predicting the 3-Year Risk of Incident Diabetes in Chinese Adults.
    Wu Y; Hu H; Cai J; Chen R; Zuo X; Cheng H; Yan D
    Front Public Health; 2021; 9():626331. PubMed ID: 34268283
    [No Abstract]   [Full Text] [Related]  

  • 16. A prediction model for type 2 diabetes risk among Chinese people.
    Chien K; Cai T; Hsu H; Su T; Chang W; Chen M; Lee Y; Hu FB
    Diabetologia; 2009 Mar; 52(3):443-50. PubMed ID: 19057891
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Metabolic and Genetic Markers Improve Prediction of Incident Type 2 Diabetes: A Nested Case-Control Study in Chinese.
    Liu J; Wang L; Qian Y; Shen Q; Yang M; Dong Y; Chen H; Yang Z; Liu Y; Cui X; Ma H; Jin G
    J Clin Endocrinol Metab; 2022 Nov; 107(11):3120-3127. PubMed ID: 35977051
    [TBL] [Abstract][Full Text] [Related]  

  • 18. German Diabetes Risk Score for the Determination of the Individual Type 2 Diabetes Risk.
    Schiborn C; Paprott R; Heidemann C; Kühn T; Fritsche A; Kaaks R; Schulze MB
    Dtsch Arztebl Int; 2022 Sep; 119(39):651-657. PubMed ID: 35915922
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prediction models for development of retinopathy in people with type 2 diabetes: systematic review and external validation in a Dutch primary care setting.
    van der Heijden AA; Nijpels G; Badloe F; Lovejoy HL; Peelen LM; Feenstra TL; Moons KGM; Slieker RC; Herings RMC; Elders PJM; Beulens JW
    Diabetologia; 2020 Jun; 63(6):1110-1119. PubMed ID: 32246157
    [TBL] [Abstract][Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 11.